It’s always an honour to be recommended from one client to another, so we were thrilled when our long-standing clients at Harrison’s Fund introduced us to Sutura Therapeutics to develop their first website.
Sutura Therapeutics are an innovative company developing RNA-targeted therapeutics to enhance the quality of life for those living with Duchenne muscular dystrophy. They are seeking to address current clinical translational bottlenecks in order to positively impact on areas within both rare and age-related diseases.
In order to connect with their community, tell their story and communicate their important research, our brief was to create a concise, easy-to-navigate site which had the flexibility to develop and evolve over time.
Using their existing branding and collaborating closely with their team, we developed a bespoke fully CMS controlled site enabling Sutura to independently manage and update the content for the site in the future. The site was naturally also designed to be fully responsive for optimal viewing across mobile, tablet and desktop to ensure maximum reach. We also helped to shape and write the content for the site, developing the tone of voice and helping to clearly present their key messages.
We are looking forward to continuing to work with Sutura on the Phase II development of the site and planning is already underway.
Learn more about Sutura Therapeutics at www.suturatherapeutics.com
Find our case study here